Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2006
07/11/2006CA2319201C Celecoxib compositions
07/11/2006CA2312915C Automatic liquid injection system and method
07/11/2006CA2309172C Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
07/11/2006CA2293793C Rapamycin formulations for oral administration
07/11/2006CA2290830C Process
07/11/2006CA2252773C Taste masked pharmaceutical compositions
07/11/2006CA2231750C Hydrolysis-promoting taxane hydrophobic derivatives
07/11/2006CA2185803C Emulsified drug delivery systems
07/11/2006CA2177972C Device for effecting the controlled release of active substances
07/11/2006CA2157921C Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof
07/11/2006CA2130867C An aerosol container and the use of an aerosol container
07/11/2006CA2129998C Improved amino acid solutions for treatment of peritoneal dialysis patients
07/06/2006WO2006072067A2 Antimicrobial biomaterial for blood bags
07/06/2006WO2006071954A2 Method of treating cancer
07/06/2006WO2006071769A1 Controlled release from block co-polymer worm micelles
07/06/2006WO2006071694A1 Visco-supplement composition and methods
07/06/2006WO2006071659A1 Delivery of h2 antagonists
07/06/2006WO2006071601A2 Therapeutic compositions for intranasal administration of ketorolac
07/06/2006WO2006071584A2 Release particle composition, process for making same, and composition having such particles
07/06/2006WO2006071373A1 Stabilization of viral compositions
07/06/2006WO2006071208A1 Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh
07/06/2006WO2006071110A1 Biodegradable hydrogels
07/06/2006WO2006071102A1 Spray-dried composition containing collectin family proteins or variants therof and process for preparing the same
07/06/2006WO2006071078A1 Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof
07/06/2006WO2006070930A1 Method for stabilizing anti-dementia drug
07/06/2006WO2006070845A1 Quick disintegration tablet and method of producing the same
07/06/2006WO2006070802A1 Transdermal patch and method of producing the same
07/06/2006WO2006070781A1 Matrix-type controlled release preparation comprising basic substance or salt thereof, and process for production of the same
07/06/2006WO2006070735A1 Stable granular pharmaceutical composition of solifenacin or its salt
07/06/2006WO2006070726A1 N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
07/06/2006WO2006070705A1 Intraoral disintegration type solid preparation containing povidone iodine
07/06/2006WO2006070673A1 Indometacin-containing adhesive patch
07/06/2006WO2006070672A1 Hydrous adhesive patch
07/06/2006WO2006070578A1 Band seal for hard capsule
07/06/2006WO2006070406A1 Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
07/06/2006WO2006070288A2 Aerosol generator
07/06/2006WO2006070248A1 Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine
07/06/2006WO2006070117A1 Novel galenic system for active principle transport, preparation method and use
07/06/2006WO2006070095A1 Stabilized crystallized catanionic nanodiscs, method for preparing same and uses thereof
07/06/2006WO2006069985A2 Production of lipid-based nanoparticles using a dual asymmetrical centrifuge
07/06/2006WO2006069938A1 Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
07/06/2006WO2006069920A1 Fast release dosage forms for antibiotics
07/06/2006WO2006069911A2 Mucoadhesive pharmaceutical compositions comprising chemoattractants
07/06/2006WO2006069719A2 Lyophilization of virosomes
07/06/2006WO2006069705A1 Directly pressed indapamide tablets with delayed release of the active substance
07/06/2006WO2006069641A1 Method for producing sterile suspensions or lyophilisates of poorly soluble basic peptide complexes, pharmaceutical formulations containing the same, and use thereof as medicaments
07/06/2006WO2006069578A1 Hyaluronic acid linked with a polymer of an alpha hydroxy acid
07/06/2006WO2006069542A1 Self-assembly luminescent conductive nano-drug crystal and its ultra-thin film and its preparation
07/06/2006WO2006069419A1 Nanoparticle composition and methods for synthesis thereof
07/06/2006WO2006058059A3 Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
07/06/2006WO2006050165A3 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
07/06/2006WO2006047590A3 Compositions and treatments of bacterial vaginosis
07/06/2006WO2006039336A3 Conveniently implantable sustained release drug compositions
07/06/2006WO2006034239A8 Antimicrobial mesoporous silica nanoparticles
07/06/2006WO2006030303A8 Oral extended release dosage form comprising a high dose biguanide and a low dose sulfonylurea
07/06/2006WO2006024479A3 Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin
07/06/2006WO2006023944A3 Pulmonary delivery of inhibitors of phosphodiesterase type 5
07/06/2006WO2006017109A3 Adhesive containing wound closure device and method
07/06/2006WO2006011159A3 Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
07/06/2006WO2005117942A3 Methods for encapsulation of biomacromolecules in polymers
07/06/2006WO2005117829A8 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
07/06/2006WO2005115346A3 Pharmaceutical composition containing risperidone
07/06/2006WO2005115330A3 Pharmaceutical compositions with enhanced performance
07/06/2006WO2005099668B1 Methods of manufacture and use of calcium phosphate particles containing allergens
07/06/2006WO2005079750A3 Films for use as dosage forms
07/06/2006WO2005077334A8 Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir
07/06/2006WO2005072776A3 Liposomal formulations of the antineoplastic agents
07/06/2006WO2004062603A3 Methods of treating lung diseases
07/06/2006US20060149220 Implantable medical device with time for therapeutic output replenishment determination and method therefore
07/06/2006US20060149183 Moisture-activatable adhesives for medical application purposes
07/06/2006US20060148982 Drug delivery
07/06/2006US20060148926 Bifunctionalized polyester material for surface treatment and biomodification
07/06/2006US20060148907 Topical antinflammatory preparations of y-terpinene
07/06/2006US20060148906 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
07/06/2006US20060148878 Pseudopolymorphic forms of carvedilol
07/06/2006US20060148877 Pharmaceutical formulations of celcoxib
07/06/2006US20060148839 New pharmaceutical compositions based on anticholinergics and tace-inhibitors
07/06/2006US20060148826 Stable aqueous solutions of risperidone and methods for their preparation
07/06/2006US20060148757 Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof
07/06/2006US20060148756 Amphiphilic macrocyclic derivatives and their analogues
07/06/2006US20060148728 Novel podophyllotoxin compositions
07/06/2006US20060148698 Storage-stable fibrinogen solutions
07/06/2006US20060148691 Sustained release preparation for therapy of coronary stenosis or obstruction
07/06/2006US20060148679 Glycosolated enkephalin agents
07/06/2006US20060148676 Polyamino acid-based particle insulin formulation
07/06/2006US20060147989 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers
07/06/2006US20060147566 Use of physiologically active fatty acids
07/06/2006US20060147544 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations
07/06/2006US20060147543 Method for controlling stability of nanofabricated polypeptide multilayer films, coatings, and microcapsules
07/06/2006US20060147542 Solid preparation containing reduced coenzyme Q10 and method for producing the same
07/06/2006US20060147541 Pharmaceutical preparation for rectal administration
07/06/2006US20060147540 Non-hygroscopic and powdery amorphous pimecrolimus
07/06/2006US20060147539 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery
07/06/2006US20060147538 Nanocomposite drug delivery composition
07/06/2006US20060147537 utilizes an adsorbent material, such as a molecular sieve, that adsorbs moisture in the inner local environment of an impermeable package, to prevent formation of Maillard products which result from chemical reactions between drug and a reducing sugar in the medical device in the presence of moisture
07/06/2006US20060147536 Method for removing fluids containing dissolved or suspended carbohydrates, lipids, metals, salts, and/or toxins from biological systems
07/06/2006US20060147535 Methods for and compositions of anticancer medicaments
07/06/2006US20060147534 Methods of inhibiting or inducing bone formation
07/06/2006US20060147533 Antimicrobial biomaterial for blood bags
07/06/2006US20060147532 Microparticles prepared using an ionic liquid